Article metrics

Download PDFPDF
1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study

 

Online download statistics by month:

Online download statistics by month: March 2024 to June 2024

AbstractFullPdf
Mar 202413507
Apr 20245900
May 20248405
Jun 20246801
Total346013